paracetamol versus ibuprofen in the management of patent ductus arteriosus (congenital heart disease) in preterm infants
Phase 4
- Conditions
- Health Condition 1: Q250- Patent ductus arteriosusHealth Condition 2: null- preterm infants with patent ductus arteriosusHealth Condition 3: P073- Preterm [premature] newborn [other]
- Registration Number
- CTRI/2018/02/011942
- Lead Sponsor
- Hinal A Sinol
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 age less than 32 weeks
2 weight less than 1250gm
3 2Decho suggestive of patent ductus arteriosus
Exclusion Criteria
1presence of congenital anomaly
2right to left ductal shunting
3liver failure
4persistent pulmonary hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method rates of ductal closure of both drugs after treatmentTimepoint: on third day of life will be assesed primary outcome
- Secondary Outcome Measures
Name Time Method the safety of both drugs including early and late adverese eventTimepoint: 7days to 30 days